NCM Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
10,147
+2
| +0% | +$222 | 0.46% | 53 |
|
|
2025
Q1 | $1.14M | Buy |
10,145
+3
| +0% | +$336 | 0.51% | 48 |
|
|
2024
Q4 | $937K | Sell |
10,142
-53
| -0.5% | -$4.9K | 0.42% | 56 |
|
|
2024
Q3 | $855K | Sell |
10,195
-97
| -0.9% | -$8.13K | 0.41% | 60 |
|
|
2024
Q2 | $706K | Buy |
10,292
+3
| +0% | +$206 | 0.37% | 68 |
|
|
2024
Q1 | $754K | Sell |
10,289
-96
| -0.9% | -$7.03K | 0.42% | 63 |
|
|
2023
Q4 | $841K | Buy |
10,385
+203
| +2% | +$16.4K | 0.51% | 54 |
|
|
2023
Q3 | $763K | Buy |
10,182
+3
| +0% | +$225 | 0.54% | 52 |
|
|
2023
Q2 | $784K | Sell |
10,179
-211
| -2% | -$16.3K | 0.55% | 52 |
|
|
2023
Q1 | $862K | Buy |
10,390
+4
| +0% | +$332 | 0.64% | 49 |
|
|
2022
Q4 | $892K | Sell |
10,386
-146
| -1% | -$12.5K | 0.59% | 49 |
|
|
2022
Q3 | $650K | Buy |
10,532
+5
| +0% | +$309 | 0.49% | 66 |
|
|
2022
Q2 | $651K | Sell |
10,527
-145
| -1% | -$8.97K | 0.46% | 71 |
|
|
2022
Q1 | $634K | Sell |
10,672
-1,877
| -15% | -$112K | 0.4% | 84 |
|
|
2021
Q4 | $911K | Buy |
+12,549
| New | +$911K | 0.81% | 39 |
|